Search research articles
Contact Us
Filters
Showing results (101-110 of 141) with videos related to
Page
of 15
Sort By:
Neurology
|
July 22, 2020
Mortality in patients with psychogenic nonepileptic seizures
Russell Nightscales, Lara McCartney, Clarissa Auvrez, et al.
European Journal of Neurology
|
February 2, 2026
Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis
Nahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
The Australian and New Zealand Journal of Psychiatry
|
February 18, 2022
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
Dhamidhu Eratne, Shorena Janelidze, Charles B Malpas, et al.
The Lancet. Child & Adolescent Health
|
March 28, 2024
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Sifat Sharmin, Izanne Roos, Charles B Malpas, et al.
BMJ Open
|
December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
Lucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Epilepsia
|
March 10, 2022
Machine learning approaches for imaging-based prognostication of the outcome of surgery for mesial temporal lobe epilepsy
Benjamin Sinclair, Varduhi Cahill, Jarrel Seah, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 15, 2018
Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease
Barbara R Cardoso, Blaine R Roberts, Charles B Malpas, et al.
Journal of Neurology
|
December 12, 2024
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
Dhamidhu Eratne, Qiao-Xin Li, Courtney Lewis, et al.
JAMA Neurology
|
July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
Nathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Annals of Neurology
|
January 5, 2019
Metabolic patterns and seizure outcomes following anterior temporal lobectomy
Varduhi Cahill, Benjamin Sinclair, Charles B Malpas, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 141) with videos related to
Sort By:
Page
of 15
Neurology
|
July 22, 2020
Mortality in patients with psychogenic nonepileptic seizures
Russell Nightscales, Lara McCartney, Clarissa Auvrez, et al.
European Journal of Neurology
|
February 2, 2026
Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis
Nahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
The Australian and New Zealand Journal of Psychiatry
|
February 18, 2022
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
Dhamidhu Eratne, Shorena Janelidze, Charles B Malpas, et al.
The Lancet. Child & Adolescent Health
|
March 28, 2024
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Sifat Sharmin, Izanne Roos, Charles B Malpas, et al.
BMJ Open
|
December 17, 2021
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
Lucy Vivash, Kelly L Bertram, Charles B Malpas, et al.
Epilepsia
|
March 10, 2022
Machine learning approaches for imaging-based prognostication of the outcome of surgery for mesial temporal lobe epilepsy
Benjamin Sinclair, Varduhi Cahill, Jarrel Seah, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 15, 2018
Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease
Barbara R Cardoso, Blaine R Roberts, Charles B Malpas, et al.
Journal of Neurology
|
December 12, 2024
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
Dhamidhu Eratne, Qiao-Xin Li, Courtney Lewis, et al.
JAMA Neurology
|
July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
Nathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Annals of Neurology
|
January 5, 2019
Metabolic patterns and seizure outcomes following anterior temporal lobectomy
Varduhi Cahill, Benjamin Sinclair, Charles B Malpas, et al.
Page
of 15